Home > Healthcare & Medical Devices > Biliary Stents Market

Biliary Stents Market Size By Type (Metal Stents, Polymer Stents), By Application (Bilio-pancreatic Leakages, Pancreatic Cancer, Benign Biliary Strictures, Gallstones), By End-use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Covid-19 Impact Analysis, Price Trends, Competitive Market Share & Forecast, 2022 - 2028

  • Report ID: GMI4034
  • Published Date: Feb 2022
  • Report Format: PDF

Industry Overview

Biliary stents market size surpassed USD 320.8 million in 2021 and is estimated to grow at over 5.1% CAGR between 2022 and 2028. Increasing incidence of gallstones coupled with the significantly rising prevalence of pancreatic and bile duct cancer are noted to boost the use of biliary stents globally. Further, an increasing adoption of Percutaneous Transhepatic Cholangiography (PTC) and Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures is also observed to significantly increase the demand for biliary stents and recurrent stenting procedures, thereby augmenting the market growth.

Global Biliary stents market

Get more details on this report - Request Free Sample PDF

Bile duct is a long tube-like structure that aids in the drainage of bile fluid. Biliary stents, also known as bile duct stents, are employed in disorders causing an obstruction in the bile duct. The bile duct stents are made up of either polymer or metallic materials. Biliary stents are inserted into the duct or lumen to keep the passage open enabling optimum drainage of the biliary fluids. Bile fluids play a major role in food digestion, and it is secreted by liver into intestinal passage through bile duct that opens in intestine.

The outbreak of COVID-19 pandemic had a negative impact on the biliary stents market as the pandemic was noted to have disrupted the healthcare system worldwide, causing significant delays in surgeries, treatment, and diagnosis of non-emergency disease conditions. With the increasing number of COVID-19 cases, several local and national regulatory bodies-imposed lockdowns, restricting the movement of people and goods. The imposed lockdowns largely affected the company’s operations while also hindering the overall market’s supply chain, resulting in the delayed and limited supply of biliary stents to end users. The significant impact of pandemic on the product delivery is also estimated to have potentially resulted in a decline in bile duct cancer care and hampered the industry growth in the initial months of the COVID-19 pandemic. Several cases also established a link between corona virus infection and a subsequent liver injury that resulted as a major complication. Hence, it is estimated to have an optimistic impact on the global market as the restrictions are eased down.

Technological advancements in various tests to detect diseases resulting the obstruction in bile duct will fuel the market statistics

The technological advancements and effective diagnosis procedures have enhanced the accuracy level of ERCP and PTC test. For instance, according to Gastrointestinal Endoscopy Journal, the overall success rate of repeat ERCP procedure is 95%. Furthermore, increasing adoption of minimally invasive procedures are propelling the market demand. Increasing technological advancements associated with the detection and treatment of gastrointestinal disorders, including bile duct obstruction, provide certain benefits such as, shorter hospital stays, lesser chances of infection, and quick recovery. Such factors are boosting the adoption rate of biliary stents contributing to the overall biliary stents market expansion.

Increasing prevalence of bile duct cancer and chronic liver disease will increase the adoption of biliary stents

The increasing population diagnosed with bile duct cancer and chronic liver disease is expected to propel the overall growth of biliary stents market globally. For instance, as of 2021, according to the American Cancer Society, about 8,000 people in U.S. are diagnosed with bile duct cancer annually. The actual number of cases are expected to be higher as these cancers can usually be hard to diagnose and might be misclassified as one of the other cancer types. Bile duct cancer can possibly lead to enlargement of a tumor blocking the bile duct. Hence, the placement of a biliary stent can assist optimum drainage of the bile.

Further, according to the CDC, in 2021, 4.5 million of adults were diagnosed with chronic liver disease in U.S. alone that contributes to 1.8% of country’s total adult population diagnosed with the disease. An inflammation in the liver as a part of liver disorders can potentially lead to the bile duct blockage, requiring the placement of a biliary stent. Owing to such aforementioned factors, the market for biliary stents is anticipated to remain driven throughout the forecast period.

High total ownership cost of the plastic bile duct stents may hinder the bile duct stents market demand

The high demand for biliary stents and recurrent stenting procedures increases the total ownership cost of biliary stents. This can potentially hinder the growth of global biliary stents market growth. Polymer stents are mainly composed of Teflon and polyethylene. The market availability of variety of configurations coupled with a relatively lower cost of polymer stents leads to a high demand for the same. However, as the polymer stents need to be replaced faster than its metallic counterparts, the overall cost of treatment associated with it significantly increases. Hence, the limited product lifecycle of polymer stents can potentially hinder the overall biliary stents market expansion.

Increasing prevalence of biliary leaks, pancreatic cancer and other malignant obstructions is increasing the demand for metal stents

By type, the market is segmented into metal stents and polymer stents. The metal stents segment accounted for nearly 64% market share in 2021 and is expected to register lucrative CAGR over the forecast period. Metal stents are mesh-like tubes composed of thin wires and are available in wide variety of lengths and diameters. The self-expandable metal stents have a post expansion diameter ranging from 6-10 mm. The major drivers of metal stents include rising incidence of bile duct -related diseases such as biliary leaks, pancreatic cancer, and other malignant obstructions, such as gallstones, leading to blockage of bile duct. The metal stents are noted to offer better patency, minimal slippage post-placement and longer lifecycle. Thus, the demand for metal stents is rapidly increasing, thereby augmenting the market outlook.

Increasing prevalence of gallstones will foster the segmental growth

Global Biliary Stents Market Share By Application

Get more details on this report - Request Free Sample PDF

By application, the biliary stents market is classified into bilio-pancreatic leakages, pancreatic cancer, benign biliary strictures, gallstones, and others. The gallstones segment accounted for USD 167.2 million revenue in 2021. Lifestyle changes such as adoption of an unhealthy and sedentary lifestyle coupled with a family history of gallstones, are observed to be some of the prominent factors leading to the high prevalence of gallstones. The occurrence of gallstones is termed as non-fatal and one of the most common diseases of the biliary system. For instance, it is estimated that nearly 20 million people in the U.S. i.e., 15% of the country’s population have gallstones. As these tend to create blockages in the biliary tract, an optimum management of gallstones is very essential. Hence, this leads to the increasing adoption of biliary stents, thereby fostering the industry growth.

Increasing preference towards minimally invasive procedures drives the growth of ambulatory surgical centers

The end-use segment of the market is bifurcated into hospitals, specialty clinics, ambulatory surgical centres, and others. The ambulatory surgical centres are expected to register more than 5.3% CAGR between 2022 and 2028. With several advantages of ambulatory care such as lowered costs, quick recovery as well as lower rates of infection coupled with the rising preference towards minimally invasive procedures, the segment is witnessing a higher demand in developed and some parts of the developing countries. Additionally, increasing adoption of biliary stents and related procedures requires minimal risk of complications to attract a wider customer base. Hence, factors such as increased adoption of minimally invasive procedures and increased healthcare expenditure are noted to drive the segment demand.

Increasing prevalence of biliary disease in female along with rising geriatric population in the North America region will drive the market growth

Global Biliary Stents Market By Region

Get more details on this report - Request Free Sample PDF

North America region accounted for over 36.5% business share of the global biliary stents market in 2021. Increasing geriatric population susceptible to diseases such as pancreatic cancer, gallstones, and other malignant obstructions are some of the major factors that will drive the regional market size. Moreover, increasing awareness of advanced technology for the diagnosis and treatment will favor the North America biliary stents industry forecasts.

Growth strategies of market players are focused on increasing the customer base

Few of the notable industry players operating in global biliary stents market include B. Braun Melsungen AG, Cook Medical Inc., Olympus Corporation, CONMED Corporation, M.I. Tech, Becton, Dickinson and Company, ENDO-FLEX GmbH, Cardinal Health, Merit Medical Systems, Inc., Medtronic plc, among others. These industry players implemented various strategies such as mergers and acquisitions, collaborations, new product launch, etc. in order to capture high revenue share in the biliary stents industry.

Some of the recent industry developments:

  • In October 2021, Boston Scientific announced that it has received the 510 (k) U.S. Food and Drug Administration clearance and CE Mark approval to market its Advanix biliary plastic stents. The approval will enhance the company’s product portfolio, thus increase the revenue of the company.
  • In October 2020, Olympus Corporation launched of VorticCatchV EndoTherapy and StoneMasterV device. These devices offer better patient outcome and promote procedural efficiency, further facilitating efficient bile duct stone management and retrieval for ERCP procedure. The product launch was aimed at expanding the company’s product offering as well as enhance its market presence.

The global biliary stents market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028, for the following segments:

By Type

  • Metal Stents
  • Polymer Stents

By Application

  • Bilio-pancreatic Leakages
  • Pancreatic Cancer
  • Benign Biliary Structures
  • Gallstones
  • Others

By End-use

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centres
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia


Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

Global market for biliary stents crossed USD 320.8 million in 2021 and is expected to expand at a CAGR of 5.1% from 2022 to 2028 driven by the surging incidence of gallstones and the increasing prevalence of pancreatic and bile duct cancer.

Metal biliary stents market held around 64% of the revenue share in 2021 and will grow with the rising incidence of bile duct-related diseases such as pancreatic cancer, biliary leaks, and other malignant obstructions.

The market share from gallstones application was around USD 167.2 million in 2021 and is expected to depict lucrative growth owing to the adoption of sedentary and unhealthy lifestyle.

North America biliary stents market captured 36.5% of the overall revenue in 2021 and is set to grow impelled by the soaring geriatric population and increasing awareness regarding advanced technology for diagnosis and treatment purposes.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 10
  • Tables & Figures: 187
  • Countries covered: 16
  • Pages: 139

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount